Zhang, Fangliang
- University of Miami School of Medicine · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #25,108
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$478.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#25,108
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Zhang, Fangliang as a PI. Multi-PI records show the full award amount for context.
- 5R01GM138557-04R01Contact PIOxidative stress response and metabolic reprogramming by protein posttranslational arginylationUniversity of Miami School of Medicine · Pharmacology (NIH department code)$314.7Kaward amount
- 5R21CA250597-03R21Contact PITargeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU)University of Miami School of Medicine · Pharmacology (NIH department code)$163.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Zhang, Fangliang as a PI.
FY2023 award administered by University of Miami School of Medicine (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Miami School of Medicine
- 2014$500K Cumulative Funding
- 2015R01 Grant Holder
- 2016$1M Cumulative Funding
- 2022$2M Cumulative Funding